Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease-Reference-Cited by-同舟云学术

Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease

Published:2019-07-15 Issue:5 Volume:12 Page:1174-1186
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Karmele Erik P., ,Pasricha Trisha S.,Ramalingam Thirumalai R.,Thompson Robert W.,Gieseck Richard L.,Knilans Kayla J.,Hegen Martin,Farmer Mark,Jin Fang,Kleinman Aaron,Hinds David A.,Almeida Pereira Thiago,de Queiroz Prado Rafael,Bing Nan,Tchistiakova Lioudmila,Kasaian Marion T.,Wynn Thomas A.,Vannella Kevin M.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41385-019-0189-6.pdf

Reference70 articles.

1. Lee, J. M. & Lee, K. M. Endoscopic diagnosis and differentiation of inflammatory bowel disease. Clin. Endosc. 49, 370–375 (2016).

2. Loftus, E. V. Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517 (2004).

3. Rubbert-Roth, A. & Finckh, A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res. Ther. 11(Suppl. 1), S1 (2009).

4. Arijs, I. et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut 58, 1612–1619 (2009).

5. Arijs, I. et al. Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease. Inflamm. Bowel Dis. 16, 2090–2098 (2010).

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-13 protects from Clostridioides difficile colitis;Anaerobe;2024-08

2. The microRNA Expression in Crypt-Top and Crypt-Bottom Colonic Epithelial Cell Populations Demonstrates Cell-Type Specificity and Correlates with Endoscopic Activity in Ulcerative Colitis;Journal of Crohn's and Colitis;2024-07-18

3. The role of eosinophilic inflammation in inflammatory bowel diseases: conductor or “first” violin?;Eosinophils and Their Role in Human Health and Disease [Working Title];2024-06-06

4. Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease;International Journal of Molecular Sciences;2024-02-28

5. Transferrin modified PEG–PLGA nanoparticles: highly effective notoginsenoside R1 formulations for the treatment of ulcerative colitis;Journal of Pharmaceutical Investigation;2024-01-04